Moderna Inc (MRNA)
$65.67+9.90%
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Cash-rich platform faces binary flu approval and cancer vaccine trials; structural revenue decline pressures near-term value.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Moderna Inc
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- $19.8B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Moderna Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free